Kazuaki Takabe Selected Research

Kazuaki Takabe Research Topics

Disease

153	Neoplasms (Cancer) 06/2024 - 08/2008
109	Breast Neoplasms (Breast Cancer) 05/2024 - 08/2008
30	Neoplasm Metastasis (Metastasis) 03/2023 - 02/2012
21	Inflammation (Inflammations) 03/2024 - 01/2013
20	Triple Negative Breast Neoplasms 03/2024 - 01/2017
10	Carcinogenesis 06/2023 - 08/2008
9	Stomach Neoplasms (Stomach Cancer) 02/2024 - 08/2008
9	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023 - 10/2016
9	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 08/2010
7	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2016
6	Adenocarcinoma 01/2023 - 01/2019
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 08/2008
5	Microsatellite Instability 11/2022 - 10/2017
5	Lymphatic Metastasis 08/2021 - 05/2012
4	Cholestasis 03/2023 - 11/2016
4	Obesity 02/2023 - 11/2017
3	Hypoxia (Hypoxemia) 08/2022 - 01/2020
3	Cicatrix (Scar) 08/2020 - 07/2019
3	Colitis-Associated Neoplasms 11/2018 - 01/2013
3	Ulcerative Colitis 01/2016 - 01/2013
3	Colitis 01/2016 - 01/2014
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 01/2022
2	Infections 06/2023 - 01/2023
2	Peritoneal Neoplasms 03/2023 - 10/2016
2	Cholangiocarcinoma 03/2023 - 01/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2022 - 08/2007
2	Disease Progression 01/2022 - 09/2014
2	Pathologic Complete Response 01/2021 - 12/2020
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 03/2018
2	Pathologic Processes 04/2020 - 12/2016

Drug/Important Bio-Agent (IBA)

43	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2024 - 08/2008
32	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2010
21	sphingosine kinaseIBA 01/2021 - 08/2008
20	LipidsIBA 04/2024 - 11/2011
16	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2008
16	SphingolipidsIBA 10/2023 - 07/2009
15	EnzymesIBA 12/2022 - 01/2017
14	Estrogen ReceptorsIBA 01/2022 - 02/2013
11	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2017
10	SphingosineIBA 10/2023 - 01/2014
9	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2017
9	Fingolimod Hydrochloride (FTY720)FDA Link 03/2023 - 11/2011
9	Messenger RNA (mRNA)IBA 01/2022 - 08/2008
8	Hormones (Hormone)IBA 02/2024 - 12/2018
8	CytokinesIBA 01/2024 - 05/2013
8	Interleukin-6 (Interleukin 6)IBA 07/2022 - 01/2014
8	Phosphotransferases (Kinase)IBA 01/2021 - 01/2014
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2017
7	Immune Checkpoint InhibitorsIBA 03/2024 - 12/2017
7	CeramidesIBA 10/2023 - 01/2016
7	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2017
6	InterferonsIBA 01/2024 - 09/2020
6	human ERBB2 proteinIBA 10/2023 - 02/2013
6	Bile Acids and Salts (Bile Acids)IBA 03/2023 - 01/2016
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2023 - 01/2021
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 11/2021
5	Sphingosine-1-Phosphate ReceptorsIBA 03/2023 - 11/2011
5	Estrogens (Estrogen)FDA Link 01/2022 - 01/2019
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 05/2013
3	Lysophosphatidic Acid ReceptorsIBA 02/2024 - 08/2008
3	Phosphates (Orthophosphate)IBA 10/2023 - 01/2016
3	NucleotidesIBA 06/2023 - 06/2020
3	Interleukin-2 (IL2)IBA 01/2023 - 05/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 11/2017
3	Complement System Proteins (Complement)IBA 07/2022 - 01/2021
3	AndrogensIBA 01/2022 - 03/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2013
3	Epidermal Growth Factor (EGF)IBA 01/2022 - 08/2008
3	palbociclibIBA 01/2021 - 12/2018
3	Immune Checkpoint ProteinsIBA 01/2021 - 12/2020
3	ChemokinesIBA 01/2021 - 05/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 11/2019
3	Histones (Histone)IBA 09/2020 - 07/2019
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2018 - 02/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2023 - 01/2014
2	Taurocholic Acid (Sodium Taurocholate)IBA 03/2023 - 04/2015
2	salicylhydroxamic acid (SHAM)IBA 03/2023 - 06/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 11/2021
2	AntigensIBA 12/2022 - 12/2017
2	Small Interfering RNA (siRNA)IBA 11/2022 - 08/2020
2	Oxygen (Dioxygen)IBA 07/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 07/2020
2	A-Form DNA (A-DNA)IBA 11/2021 - 01/2021
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 05/2019
2	Annexin A1IBA 01/2021 - 08/2019
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 08/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 12/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 12/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2020 - 01/2019
2	Protein Isoforms (Isoforms)IBA 04/2020 - 01/2016
2	Everolimus FDA Link 01/2020 - 12/2018

Therapy/Procedure

40	Therapeutics 02/2024 - 08/2008
24	Neoadjuvant Therapy 03/2024 - 05/2019
23	Drug Therapy (Chemotherapy) 06/2024 - 08/2008
9	Immunotherapy 01/2023 - 01/2016
5	Precision Medicine 01/2022 - 12/2016
4	Radiotherapy 06/2024 - 09/2016
2	Oral Administration 10/2023 - 01/2016
2	Adjuvant Chemotherapy 12/2019 - 01/2017